Related Experiment Video
Updated: Jan 18, 2026
Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
Published on: November 10, 2023
The discussion on the differences in immune microenvironment between low-risk and high-risk myelodysplastic syndromes
Yinglong Wang1, Xingdong Xiao2, Hanxue Zheng1
1The Second Clinical Medical College of Lanzhou University, Lanzhou, China.
Abstract:
This review aims to examine differences in the immune microenvironment between low-risk and high-risk myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). Furthermore, it explores the impact of immune cell imbalance, abnormal cytokine levels, and stromal cell impairment on disease progression and prognosis. Additionally, the review analyzes the immune mechanisms underlying the transformation of high-risk MDS to AML. These findings provide valuable insights for both prognostic stratification of MDS by means of immune markers and the development of targeted therapies for AML.
More Related Videos
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
06:39Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
Related Concept Videos
01:15Differentiation of Common Myeloid Progenitor Cells
01:27Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...